CAPS Trial: Cannabidiol Youth Anxiety Pilot Study (open-label completed, 2020) This study ran for 12 weeks and involved 31 participants aged 12-25 who were diagnosed with severe anxiety disorders and failed to respond to cognitive behavioural therapy (CBT) sessions,...
PRESS RELEASEFor Immediate Release Australian Natural Therapeutics Group and NUBU Pharmaceuticals advance New Zealand’s medicinal cannabis market. Byron Bay, Australia – In a landmark collaboration, Australian Natural Therapeutics Group (ANTG), a leader in...
Mark also got to discuss New Zealand's only medical device vaporisers, The Mighty Medic, The Mighty Medic + and the Volcano Medic 2 from Storz & Bickel GmbH - for those not interested in "High Tea". These are available nationwide now, but if you would like some...
The 18-month trial will look at the level of impairment medicinal cannabis can cause. It will not take place on public roads to ensure there's no safety risk to participants or members of the public, a government spokeswoman said. "Safety on our roads is our number...